Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China

References

• Gambacciani M, Biglia N, Cagnacci A, et al. Menopause and hormone replacement therapy: the 2017 recommendations of the Italian Menopause Society. Minerva Ginecol. 2018;70(1):27–34.
   PubMed Web of Science ®Google Scholar
• Baber RJ, Panay N, Fenton A, The IMS Writing Group. IMS recommendations on women’s midlife health and menopause hormone therapy. Climacteric. 2016;19(2):109–150. doi: 10.3109/13697137.2015.1129166.
   PubMed Web of Science ®Google Scholar
• The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728–753. doi: 10.1097/GME.0000000000000921.
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975–4011. doi: 10.1210/jc.2015-2236.
   PubMed Web of Science ®Google Scholar
• Cobin RH, Goodman NF, AACE Reproductive Endocrinology Scientific Committee. Goodman NF on behalf of the AACE reproductive endocrinology scientific committee. Endocr Pract. 2017;23(7):869–880. doi: 10.4158/EP171828.PS.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence (NICE). Clinical guideline. Methods, evidence and recommendations. Version 1.2; 2015 [cited 2021 Feb 21]. Available from: https://www.nice.org.uk/guidance/ng23/documents/menopause-full-guideline2.
   Google Scholar
• Hamoda H, Panay N, Pedder H, et al. The British Menopause Society & Women’s Health concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020;26(4):181–209. doi: 10.1177/2053369120957514.
   PubMedGoogle Scholar
• Menopause Group of the Chinese Medical Association Obstetrics and Gynecology Branch. Menopause management and menopausal hormone therapy in China. Chinese J Obstet Gynecol. 2018;53(11):729–739. doi: 10.3760/cma.j.issn.0529-567x.2018.11.001.
   Google Scholar
• ] Menopause Subgroup of the Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. The 2023 Chinese menopause symptom management and menopausal hormone therapy guidelines. Zhonghua Fu Chan Ke Za Zhi. 2023;58(1):4–21. doi: 10.3760/cma.j.cn112141-20221118-00706.
   PubMedGoogle Scholar
• Yu Q. Population education of menopausal knowledge in China. Climacteric. 2019;22(4):323–323. doi: 10.1080/13697137.2019.1609767.
   PubMed Web of Science ®Google Scholar
• Jin F, Tao MF, Teng YC, et al. Knowledge and attitude towards menopause and hormone replacement therapy in chinese women. Gynecol Obstet Invest. 2015;79(1):40–45. doi: 10.1159/000365172.
   PubMed Web of Science ®Google Scholar
• Chu K, Song Y, Chatooah ND, et al. The use and discontinuation of hormone replacement therapy in women in South China. Climacteric. 2018;21(1):47–52. doi: 10.1080/13697137.2017.1397622.
   PubMed Web of Science ®Google Scholar
• Chen R, Yu Q. Current status of physicians’ awareness and clinical practice of menopause hormone replacement therapy in China: a multicenter, cross-sectional survey. Maturitas. 2015;82(3):316–317. doi: 10.1016/j.maturitas.2015.06.012.
   Google Scholar
• Gao L, Wu X, Liu X, et al. Awareness of hormone replacement therapy in medical care personnel in Jiaxing, China: a questionnaire survey. Gynecol Endocrinol. 2018;34(4):332–335. doi: 10.1080/09513590.2017.1405929.
   PubMed Web of Science ®Google Scholar
• Zhen X, Sun X, Dong H. Health technology assessment and its use in drug policies in China. Value Health Reg Issues. 2018;15:138–148. doi: 10.1016/j.vhri.2018.01.010.
   PubMedGoogle Scholar
• Bao Peng L, Tan CQ, Wan XM, et al. Cost-utility analysis in China: differences and difficulties compared with developed countries. Pharmacoeconomics. 2007;25(7):619. doi: 10.2165/00019053-200725070-00007.
   PubMed Web of Science ®Google Scholar
• Liu GG, Shanlian H, Jiuhong W, et al. China guidelines for pharmacoeconomic evaluations. 2020 Edition. Beijing: China Society for Pharmacoeconomics and Outcomes Research; 2020.
   Google Scholar
• Velentzis LS, Salagame U, Canfell K. Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations. BMC Health Serv Res. 2017;17(1):326. doi: 10.1186/s12913-017-2227-y.
   PubMedGoogle Scholar
• Barton P, Bryan S, Robinson S. Modelling in the economic evaluation of health care: selecting the appropriate approach. J Health Serv Res Policy. 2004;9(2):110–118. doi: 10.1258/135581904322987535.
   PubMedGoogle Scholar
• Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006;15(12):1295–1310. doi: 10.1002/hec.1148.
   PubMed Web of Science ®Google Scholar
• Lekander I, Borgström F, Ström O, et al. Cost-effectiveness of hormone therapy in the United States. J Womens Health. 2009;18(10):1669–1677. doi: 10.1089/jwh.2008.1246.
   Web of Science ®Google Scholar
• Lekander I, Borgström F, Ström O, et al. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK-results based on the women’s health initiative randomised controlled trial. Bone. 2008;42(2):294–306. doi: 10.1016/j.bone.2007.09.059.
   PubMed Web of Science ®Google Scholar
• Zethraeus N, Borgström F, Jönsson B, et al. Reassessment of the cost-effectiveness of hormone replacement therapy in Sweden: results based on the women’s health initiative randomized controlled trial. Int J Technol Assess Health Care. 2005;21(4):433–441. doi: 10.1017/S0266462305050609.
   PubMed Web of Science ®Google Scholar
• Ylikangas S, Bäckström T, Heikkinen J. Cost-effectiveness of continuous combined hormone replacement therapy in long-term use: economic evaluation based on a 9-year study in Finland. Curr Med Res Opin. 2007;23(1):57–64. doi: 10.1185/030079907X159542.
   PubMed Web of Science ®Google Scholar
• Lumsden MA, Davies M, Sarri G, Guideline Development Group for Menopause: diagnosis and Management (NICE Clinical Guideline No. 23). Sarri G for the guideline development group for menopause: diagnosis and management. Diagnosis and management of menopause the national institute of health and care excellence guideline. JAMA Intern Med. 2016;176(8):1205–1206. doi: 10.1001/jamainternmed.2016.2761.
   PubMed Web of Science ®Google Scholar
• Medicines and Healthcare Products Regulatory Agency. Drug safety update volume 13, issue 2: September 2019. First published online 30 August; 2019 [cited 2021 Mar 5]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/832681/Sept-2019-PDF.pdf.
   Google Scholar
• World Health Organisation. China Life Table, females, age specific, all-cause mortality; 2020 [cited 2020 Jun 24]. Available from: https://apps.who.int/gho/data/view.main.60340.
   Google Scholar
• Paisley S. Classification of evidence in decision-analytic models of cost-effectiveness: a content analysis of published reports. Int J Technol Assess Health Care. 2010;26(4):458–462. doi: 10.1017/S026646231000098X.
   PubMed Web of Science ®Google Scholar
• Edlin RM, Hulme C, Hall P, et al. Cost effectiveness modelling for health technology assessment, a practical course. Switzerland: Springer; 2015.
   Google Scholar
• Nuijten MJ. The selection of data sources for use in modelling studies. Pharmacoeconomics. 1998;13(3):305–316. doi: 10.2165/00019053-199813030-00005.
   PubMed Web of Science ®Google Scholar
• China diagnosis related group codes and data provided by Abbott Affiliate. 2020.
   Google Scholar
• Rautenberg TA, Ng SKA, Downes M. A cross-sectional study of symptoms and health-related quality of life in menopausal-aged women in China. BMC Women’s Health. 2023;23(1):563. doi: 10.1186/s12905-023-02728-y.
   PubMed Web of Science ®Google Scholar
• Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases. BMJ. 2020;371:m3873. doi: 10.1136/bmj.m3873.
   PubMed Web of Science ®Google Scholar
• Kim J-E, Chang J-H, Jeong M-J, et al. A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases. Sci Rep. 2020;10(1):20631. doi: 10.1038/s41598-020-77534-9.
   PubMed Web of Science ®Google Scholar
• Gartlehner G, Patel SV, Feltner C, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: evidence report and systematic review for the US preventive services task force. JAMA. 2017;318(22):2234–2249. doi: 10.1001/jama.2017.16952.
   PubMed Web of Science ®Google Scholar
• Feng R-M, Zong Y-N, Cao S-M, et al. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39(1):22. doi: 10.1186/s40880-019-0368-6.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet. 2016;387(10015):251–272. doi: 10.1016/S0140-6736(15)00551-6.
   PubMed Web of Science ®Google Scholar
• Rautenberg T, Hodgkinson B, Zerwes U, et al. Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer. BMC Cancer. 2022;22:52. doi: 10.1186/s12885-021-09140-5.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lei J, Shao X, et al. Trends in hospitalization and in-Hospital mortality from VTE 2007 to 2016, in China. Chest. 2019;155(2):342–353.
   PubMed Web of Science ®Google Scholar
• Cui Z, Feng H, Meng X, et al. Age-specific 1-year mortality rates after hip fracture based on the populations in mainland China between the years 2000 and 2018: a systematic analysis. Arch Osteoporos. 2019;14(1):55. doi: 10.1007/s11657-019-0604-3.
   PubMed Web of Science ®Google Scholar
• Boardman HMP, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;2015(3):Cd002229. doi: 10.1002/14651858.CD002229.pub4.
   PubMedGoogle Scholar
• Pan R, Zhu M, Yu C, et al. Cancer incidence and mortality: a cohort study in China, 2008–2013. Int J Cancer. 2017;141(7):1315–1323. doi: 10.1002/ijc.30825.
   PubMed Web of Science ®Google Scholar
• Ma LY, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatric Cardiology. 2020;17(1):1–8.
   Web of Science ®Google Scholar
• Schwander B, Hiligsmann M, Nuijten M, et al. Replication of published health economic obesity models: assessment of facilitators, hurdles and reproduction success. Pharmacoeconomics. 2021;39(4):433–446. doi: 10.1007/s40273-021-01008-7.
   PubMed Web of Science ®Google Scholar
• Salpeter SR, Buckley NS, Liu H, et al. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med. 2009;122(1):42–52.e2. doi: 10.1016/j.amjmed.2008.07.026.
   PubMed Web of Science ®Google Scholar
• Caro JJ, Briggs AH, Siebert U; on behalf of the ISPOR-SMDM Modeling Good Research Practices Task Force, et al. Modeling good research practices–overview: a report of the ISPOR-SMDM modeling good research practices task force-1. Value Health. 2012;15(6):796–803. doi: 10.1016/j.jval.2012.06.012.
   PubMed Web of Science ®Google Scholar
• Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Value Health. 2013;16(2):e1-5–e5. doi: 10.1016/j.jval.2013.02.010.
   PubMed Web of Science ®Google Scholar
• Liu K, He L, Tang X, et al. Relationship between menopause and health-related quality of life in middle-aged Chinese women: a cross-sectional study. BMC Womens Health. 2014;14:7.
   PubMed Web of Science ®Google Scholar
• Palacios S, Stevenson JC, Schaudig K, et al. Hormone therapy for first-line management of menopausal symptoms: practical recommendations. Women Health. 2019;15:1–8.
   Google Scholar
• Yang Y, Tian K, Bai G, et al. Health technology assessment in traditional Chinese medicine in China: current status, opportunities, and challenges. Global Health J. 2019;3(4):89–93. doi: 10.1016/j.glohj.2019.11.002.
   Google Scholar
• Li Y, Zheng H, Zheng Q, et al. Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials. 2014;15(1):198. doi: 10.1186/1745-6215-15-198.
   PubMedGoogle Scholar